ViiV Healthcare acquires late-stage HIV R&D assets from BMS
Posted on25 Feb 2016
TagsBMS, Bristol-Myers Squibb, R&D assets, ViiV Healthcare, ViiV Healthcare acquires late-stage HIV R&D assets from BMS
Comments0
GlaxoSmithKline plc, one of the world’s leading research-based pharmaceutical and healthcare companies, announced that ViiV Healthcare, the global specialist HIV company majority... Read More